原发性醛固酮增多症患者单侧肾上腺切除后长期盐摄入减少
本研究为观察性纵向队列研究,纳入德国Conn注册数据库148例原发性醛固酮增多症患者(单侧66例,双侧82例),通过24小时尿钠排泄量化治疗前后盐摄入。单侧患者基线尿钠显著高于双侧,单侧肾上腺切除后1年尿钠自发下降并持续至3年,而双侧患者MRA治疗无显著变化。
要点
- 单侧PA患者基线尿钠高于双侧(205 vs 178 mmol/d,P=0.047)。
- 单侧肾上腺切除后1年尿钠降至176 mmol/d(P=0.012),3年仍低。
- 双侧PA患者MRA治疗前后尿钠无显著变化(179 vs 183 mmol/d)。
核心结论
- 单侧PA患者肾上腺切除后尿钠排泄显著下降并长期维持,而双侧PA患者MRA治疗无此变化。
研究设计与样本
- 观察性纵向队列研究,纳入德国Conn注册数据库148例连续PA患者(单侧66例,双侧82例)。
- 通过24小时尿钠排泄量化治疗前后盐摄入,随访至3年。
主要发现
- 基线单侧PA患者尿钠显著高于双侧(205 vs 178 mmol/d,P=0.047)。
- 尿钠较高与心血管风险特征相关,包括蛋白尿、脂质和糖代谢异常,并需更高剂量降压药。
- 单侧PA肾上腺切除后1年尿钠降至176 mmol/d(P=0.012),3年随访仍低(174 mmol/d)。
- 双侧PA患者MRA治疗前后尿钠无显著变化(179 vs 183 mmol/d)。
临床怎么用
- 对单侧PA患者,肾上腺切除可能有助于长期减少盐摄入,从而改善心血管风险。
- 双侧PA患者接受MRA治疗时,可能需额外强调限盐以降低盐摄入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: High dietary salt intake is known to aggravate arterial hypertension. This effect could be of particular relevance in the setting of primary aldosteronism (PA), which is associated with cardiovascular damage independent of blood pressure levels. The aim of this study was to determine the impact of therapy on salt intake in PA patients. PATIENTS AND METHODS: A total of 148 consecutive PA patients (66 with unilateral and 82 with bilateral PA) from the database of the German Conn's Registry were included. Salt intake was quantified by 24-hour urinary sodium excretion before and after initiation of PA treatment. STUDY DESIGN: Observational longitudinal cohort study. SETTING: Tertiary care hospital. RESULTS: At baseline, unilateral PA patients had a significantly higher urinary sodium excretion than patients with bilateral disease (205 vs 178 mmol/d, P = 0.047). Higher urinary sodium excretion correlated with an increased cardiovascular risk profile including proteinuria, impaired lipid, and glucose metabolism and was associated with higher daily doses of antihypertensive drugs to achieve blood pressure control. In unilateral disease, urinary sodium excretion dropped spontaneously to 176 mmol/d (P = 0.012) 1 year after unilateral adrenalectomy and remained low at 3 years of follow-up (174 mmol/d). In contrast, treatment with mineralocorticoid receptor antagonists (MRA) in bilateral PA patients was not associated with a significant change in urinary sodium excretion at follow-up (179 mmol/d vs 183 mmol/d). CONCLUSION: PA patients consuming a high-salt diet, estimated based on urinary sodium excretion, respond to adrenalectomy with a significant reduction of salt intake, in contrast to MRA treatment.
引用
- Adolf C, Heinrich DA, Holler F, et al. Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake. J Clin Endocrinol Metab. 2020. PMID: 31702016. doi:10.1210/clinem/dgz051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。